Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Leczna – page 26

865 clinical trials in Leczna, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Leczna at a glance
865
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

865 trials in Leczna

Open in trial search

Type 2 diabetes mellitus+2

Not yet recruiting

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Olatorepatide
  • Sponsor:Regeneron Pharmaceuticals Inc.

Dermatitis atopic

Not yet recruiting

A Phase 2b Study Evaluating the Efficacy and Safety of ENV-294 in Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ENV-294
  • Sponsor:Enveda Therapeutics Inc.

Type 2 diabetes mellitus

Not yet recruiting

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Ocular myasthenia

Not yet recruiting

Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rozanolixizumab
  • Sponsor:UCB Biopharma

Plasma cell myeloma

Not yet recruiting

Dapagliflozin for Primary Cardioprotection in Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation – A Randomized Phase 2 Study

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Instytut Hematologii I Transfuzjologii

Asthma

Not yet recruiting

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Chiesi Farmaceutici S.p.A.

Obesity

Not yet recruiting

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:HRS 9531
  • Sponsor:Kailera Therapeutics Inc.

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Muvalaplin
  • Sponsor:Eli Lilly & Co.

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:JNJ-88545223
  • Sponsor:Janssen Cilag International

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Parkinson's disease

Not yet recruiting

A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ioflupane (123I)
  • Sponsor:Biohaven Therapeutics Ltd.

Dermatitis atopic

Not yet recruiting

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:IMG-007
  • Sponsor:Inmagene LLC

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Leczna

What the registry says about research in the country

01 Infectious Disease Prevention

Studies focusing on preventive vaccines and treatments for various infectious diseases, including research on meningococcal and pneumococcal vaccines for infants and toddlers, plus investigations into respiratory syncytial virus (RSV) prevention.

  • Meningococcal ACYW conjugate vaccine trials
  • Pneumococcal vaccine safety studies
  • RSV prevention research

Emphasis on immunogenicity and safety profiles in pediatric populations.

02 Gastrointestinal Disorders

Comprehensive research into inflammatory bowel conditions, with multiple trials examining new treatments for Crohn's disease and ulcerative colitis. Studies include novel therapeutic approaches and treatment targets.

  • Obefazimod efficacy studies
  • TEV-48574 clinical evaluation
  • Celiac disease symptom management

Focus on achieving both clinical and endoscopic remission in patients.

03 Critical Care Medicine

Investigations into treatments for severe conditions, including viral lung infections and acute bleeding management. Studies evaluate innovative therapies and emergency interventions.

  • Tozorakimab for respiratory support
  • Anticoagulation reversal studies
  • Burn treatment innovations

Research aimed at improving patient outcomes in urgent care situations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.